Key Takeaway: Exicure, Inc. has published its unaudited proforma consolidated balance sheets for October 31, 2024, and December 17, 2024. The financial data reveals a notable increase in total assets from $10,163,000 to $12,912,000, primarily driven by an increase in cash and cash equivalents. However, the company's accumulated deficit has worsened slightly, indicating ongoing financial challenges. Total liabilities have decreased marginally, reflecting a positive trend in financial management.
Price reaction · baseline $18.12 (2024-12-16 close) · hit after-hours · 1 other XCUR headline(s) in the window, move may be shared
day 0 close · peak
+2.3%
Market Sentiment Analysis
POSITIVE FACTORS
Significant increase in cash and cash equivalents from $597k to $3,574k.
Total assets have risen from $10,163k to $12,912k, indicating growth.
CONCERNS & RISKS
Accumulated deficit has slightly increased from ($192,443k) to ($192,640k).
Total liabilities remain significant, but have decreased slightly from $8,979k to $8,627k.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+35%
120-day peak, hindsight
Typical move
19.3%
average across 2 past catalysts
Cash runway
~5 mo
High dilution risk
Lead asset
GPC-100
Phase 2 · Multiple Myeloma
Full Press Release Details
UNAUDITED PROFORMA CONSOLIDATED BALANCE SHEETS
October 31, 2024 (Unaudited)
December 17, 2024 (Pro Forma)
ASSETS
Current assets
Cash and cash equivalents
$
597
$
3,574
Other receivable
800
921
Prepaid expenses and other current assets
929
889
Total current assets
2,326
5,384
Property and equipment, net
31
29
Right-of-use asset
5,858
5,790
Other noncurrent assets
1,948
1,709
Total assets
$
10,163
$
12,912
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities
Accounts payable
1,267
1,261
Accrued expenses and other current liabilities
2,354
2,080
Total current liabilities
3,621
3,341
Lease liability, noncurrent
5,358
5,286
Total liabilities
8,979
8,627
Commitments and Contingencies
Stockholders' equity
Preferred stock, $0.0001 par value per share
-
-
Common stock, $0.0001 par value per share
-
-
Additional paid-in capital
193,627
196,925
Accumulated deficit
(192,443)
(192,640)
Total stockholders' equity
1,184
4,285
Total liabilities and stockholders' equity
$
10,163
$
12,912
Frequently Asked Questions
What are the total current assets on October 31, 2024?
$2,326 is the total current assets as of October 31, 2024.
What is the total liabilities amount by December 17, 2024?
The total liabilities on December 17, 2024, amount to $8,627.
How much is the accumulated deficit by December 17, 2024?
The accumulated deficit by December 17, 2024, is $(192,640).
What is the total stockholders' equity as of October 31, 2024?
Total stockholders' equity on October 31, 2024, is $1,184.
Did total assets increase from October 2024 to December 2024?
Yes, total assets increased from $10,163 to $12,912.